Gå til indhold
Symphogen logo

Postdoc-forsker med fokus på In Silico Prædiktive Metoder til Antistofrensning

Symphogen · Pharma og life science

Resumé

Denne Postdoc-forskerrolle fokuserer på at udvikle og implementere in silico prædiktive metoder til antistofrensning inden for en farmaceutisk ramme. Stillingen sigter mod at skabe et digitalt framework til at guide renseringsstrategier for komplekse antistofformater, hvilket reducerer forsøg-og-fejl-eksperimenter og accelererer arbejdsgange.

Nøgleoplysninger

Status
Ledig· for 19 dage siden
Sted
Ballerup
Kontraktens længde
18 måneder
Arbejdsform
På stedet
Niveau
Nyuddannet
Uddannelse
Kandidat
Påkrævede kompetencer
  • in silico prædiktive metoder
  • antistofrensning
  • kromatografiske datasæt
  • sekvensbaseret rensemodellering
  • bispecifikke
  • aggregater
Goder
  • mulighed for forlængelse
Løn (estimeret, uofficiel)
~kr. 510k–614k/yrVejledende for en fuldtidsstilling; arbejdsgiveren har ikke oplyst et beløb Hvordan beregnes dette?

Fuld beskrivelse

Join Servier Symphogen as a Postdoc Scientist to pioneer in silico predictive methods for antibody purification and implementation in established purification workflows.

This 18-month Postdoctoral Scientist appointment, which includes the possibility of extension, represents a unique opportunity to gain experience in an established pharmaceutical setting. The cross‑functional nature of the role serves as excellent preparation for future professional advancement in industry.

You will evaluate and establish in silico methods to guide antibody purification strategies based on protein sequences, refining these in silico procedures for integration into existing purification workflows to increase efficiency.

You will join the Purification team within Drug Substance Development at Servier Symphogen and work closely with colleagues from Drug Substance Development, as well as from Research and Analytical teams.

The project aims to develop a digital framework for guiding purification strategies for complex antibody formats, including bispecifics and other high‑complexity modalities.

It addresses the challenge of product‑related impurities, such as mispaired species and aggregates, by limiting the number of trial‑and‑error experiments.

By integrating in silico tool evaluation with wet‑lab chromatographic datasets, the project aims to identify correlations to enable sequence‑based purification modeling.

Ultimately, this approach standardises and accelerates current purification workflows, ensuring complex antibody formats reach patients with efficiency and consistently high quality.

Søg på virksomhedens side